There were significant differences in the patterns of tumor enhancement, lymph node metastasis, and HER2 between death (P < 0.05) and Exp (B) (expose of the B coefficient), namely 4.555, 9.384 and 4.091, respectively. Here, ERBB2 is linked to metastatic malignant neoplasm in the lymph nodes.